share_log

Form 144 | Supernus Pharmaceuticals(SUPN.US)高管拟出售12.5万股股份,价值约453.59万美元

Form 144 | Supernus Pharmaceuticals(SUPN.US) Officer Proposes to Sell 4.54 Million in Common Stocks

Moomoo News ·  Nov 9 06:05

SEC FILLINGS DISCLOSED/ Nov 8, $Supernus Pharmaceuticals (SUPN.US)$ Officer JACK A KHATTAR intends to sell 125K shares of its common stock on Nov 8, with a total market value of approximately $4.54 million.

JACK A KHATTAR has reduced shareholding in $Supernus Pharmaceuticals (SUPN.US)$ by 125K shares since Nov 7, 2024, with a total value of approximately $4.58 million.

1731103541035069559.png

What is Form 144?

Form 144: Notice of Proposed Sale of Securities is a document issued by the Securities and Exchange Commission (SEC). Individuals such as executive officers and affiliates of a US-listed company must submit this form to the SEC when they intend to sell more than 5,000 shares or units of that company's stock, or if the sale price adds up to more than $50,000 in any three-month period. This regulation is known as Rule 144, under the Securities Act of 1933.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment